Company intelligence / Profile preview

Alzeca Biosciences

Houston, Texas, United Statesalzeca.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Alzeca Biosciences has demonstrated in preclinical studies that its proprietary ADx nanoparticle imaging agent can cross the blood-brain barrier and bind specifically to amyloid plaques. This enables high-resolution detection of early-stage Alzheimer’s pathology using standard MRI equipment. Preliminary toxicity studies have been successful, with plans for human clinical trials announced but not confirmed as started by latest public information.

Therapeutic areas
Neurology
Modalities
Nanoparticle-based imaging agentsIntravenous contrast agents for MRI/CT
Industry
Medical Imaging
02

Drug pipeline

1 asset

ADx

Pre-clinical
Indications
Alzheimer's disease
03

Partnerships

Academic collaborations with Texas Children’s Hospital and University of Houston during technology development phase.[2]Supported by grants from NIH, Cure Alzheimer’s Fund, Alzheimer’s Association, Alliance for NanoHealth.[1]

Beyond the preview

Go deeper on Alzeca Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alzeca Biosciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call